Table S1 from Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer
In this study, a total of 12 differentially expressed lncRNAs were established through lncRNA sequencing analysis. Lnc005620 is one of the novel intronic lncRNAs which is highly expressed in Epi-R MDA
Table S1. Table indicating with which public dataset each sample is associated. Table S2. Differentially expressed genes between long-term treated and pre-treatment dormant tumours. Table S3. Enriched
Pancreatic cancer represents one of the most lethal tumours, characterised by an immunosuppressive microenvironment and a lack of cytotoxic immune cell infiltrates, which confers resistance to immunot
Combined therapy of vistusertib with fulvestrant showed synergy in estrogen receptor positive PDX models of resistance to endocrine therapy and delayed tumour progression after cessation of therapy. T
